Sort
64,565 grants matching “drug discovery”
Toward targeting bacterial metabolism: Relevance, mechanism and function of DXP synthase
$640,497Caren L. Freel Meyers · Johns Hopkins University · R56 · FY2020 · AI
Chemoprotectants for Head-Neck Therapeutics
$640,454Haiching Ma · Reaction Biology Corporation · R44 · FY2012 · CA
Leveraging electronic medical records to perform large-scale diabetes pharmacogenomics among ancestrally diverse patient populations
$640,328Keoki Williams · Henry Ford Health System · R01 · FY2019 · DK
Hit-to-lead optimization for sleeping sickness drug discovery
$640,299Michael P Pollastri · Northeastern University · R01 · FY2016 · AI
Discovery of Bifunctional NOP/Opioid Receptor Ligands for Drug Abuse Therapy
$640,287Nurulain T Zaveri · Astraea Therapeutics, Llc · R01 · FY2010 · DA
Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDP
$640,216Peter Alexander Ljubenkov · University Of California, San Francisco · R01 · FY2022 · AG
Free radical strategies for bioactive molecule synthesis
$640,172Corey Stephenson · University Of Michigan At Ann Arbor · R35 · FY2024 · GM
Drug Abuse: Discovering Ligands for Pertinent GPCRs
$640,139Marc G. Caron · Duke University · P30 · FY2017 · DA
Project 1
$640,134Duygu Tosun-Turgut · Northern California Institute/Res/Edu · U19 · FY2022 · AG
RECOVERY OF OPTICAL ABSORPTION COEFFICIENT IN QUANTITATIVE PHOTOACOUSTIC IMAGING
$640,128Lihong Wang · Washington University · R01 · FY2011 · EB
Nano-scale proteomic analysis: development, implementation, and applications
$640,087Jinqiu Chen · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease
$640,084Opeyemi Ayodeji Olabisi · Duke University · R01 · FY2025 · MD
The Impact of Pharmaceutical Industry Messaging on the Opioid Crisis among U.S. Military Veterans
$640,079Christopher Keith Haddock · Ndri-Usa, Inc. · R01 · FY2024 · DA
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling
$640,003Thomas E Ferrin · University Of California, San Francisco · R01 · FY2018 · GM
Psychosis Genetics Research in Africa: Building Capacity by Investing in People
$639,949Karestan C Koenen · Broad Institute, Inc. · R01 · FY2020 · MH
Small molecule mimetics of Humanin that normalize neuronal p-Akt as novel therapeutics for AD
$639,946Varghese John · University Of California Los Angeles · R01 · FY2024 · AG
Retrovirus Evolution
$639,885John M Coffin · Tufts University Boston · R37 · FY2008 · CA
Development of a Porcine Model of Atherosclerosis
$639,811Christopher Rogers · Exemplar Genetics, Llc · R44 · FY2011 · HL
Intervention Core for the Dietary Biomarkers Development Center at Harvard University
$639,807Frank M Sacks · Harvard School Of Public Health · U2C · FY2022 · DK
Does neurotransmitter plasticity of para-serotonergic neurons augment autoresuscitation following perinatal stress and buffer SIDS risk?
$639,798Susan M Dymecki · Harvard Medical School · R01 · FY2022 · HD
Does neurotransmitter plasticity of para-serotonergic neurons augment autoresuscitation following perinatal stress and buffer SIDS risk?
$639,798Susan M Dymecki · Harvard Medical School · R01 · FY2023 · HD
Does neurotransmitter plasticity of para-serotonergic neurons augment autoresuscitation following perinatal stress and buffer SIDS risk?
$639,766Susan M Dymecki · Harvard Medical School · R01 · FY2021 · HD
Brain-selective estrogen therapy for menopausal hot flushes in an advanced translational animal model
$639,751Istvan Jozsef Merchenthaler · University Of Maryland Baltimore · R01 · FY2021 · AG
Operations and clinical assesment core
$639,749William T Carpenter · University Of Maryland Baltimore · P50 · FY2008 · MH
Pharmacology of HIV Viral DNA Retroviral Integrases
$639,646Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA